2019年9月26日 星期四

Mstar of SIVB Apr 2018

Investors searching for banks sensitive to interest rates will be disappointed.
Colin Plunkett
Equity Analyst
Business Strategy and Outlook 
| by Colin Plunkett Aug 10, 2018

Though 2017 was a great year for Silicon Valley Bank loan and deposit growth, we believe that Silicon Valley Bank is entering a period of lower returns from increasing competition and declining credit quality. Recently, management has said the company has benefited from sovereign wealth funds and SoftBank's aggressive investment campaign. We suspect these atypical investors represent the last of the few remaining pillars of funding supporting venture capital activity.

One concerning trend of this tech cycle is the use of leverage by venture-capital-backed startups. Unlike in 2001, where equity was often the sole funding source, venture debt has played an increasing role at early-stage companies. Rather than dilute its equity stake, Uber has raised more than $3 billion in debt from major banks. WeWork, another unicorn with an unproven business model, has reportedly sought to obtain a $750 million credit line. Industrywide, we believe that as a result of rising competition, there has been a decline in underwriting quality by providing startups debt earlier in their life cycle. Too frequently, we have observed Silicon Valley Bank's public borrowers do not generate cash or have the asset coverage to take on significant debt. Yet, Silicon Valley Bank has been willing to provide them with loans.

Given that Silicon Valley Bank grew loans at a 20% compound annual rate the past five years in a venture debt market that has become highly competitive, we believe a significant rise in charge-offs accompanied by slower growth is inevitable. We forecast charge-offs will increase to almost 2% in 2019 and 2020 and decline thereafter, though we'd warn this could be substantially higher. We don't think the bank's loans are as good as in previous cycles, given industrywide trends. We also believe the bank will see significant negative loan growth in a venture capital downturn. In past downturns, loans have contracted by as much as 18%. Silicon Valley Bank has experienced tremendous growth in capital call lines, which could lead to loan balances falling farther than they have in previous downturns. We expect to see loans contract by 20%-25% from peak levels over our forecast period.

Economic Moat 
| by Colin Plunkett Aug 10, 2018

Despite having an impressively cheap source of commercial deposits, in our view, SVB Financial does not possess a moat. We do not expect Silicon Valley Bank to generate significant excess returns. Historically, banks have established moats through cost advantages, customer loyalty through high switching costs, or structural advantages in the banking system in which they operate. In 2017, 80% of Silicon Valley Bank's deposits were non-interest-bearing, and we calculated a total cost of deposits at less than 2 basis points annually, an extremely low number. In comparison, Wells Fargo, a bank that's more than 10 times the size and achieved a wide moat partly through cheap retail deposits, has a total cost of deposits of less than 8 basis points. In addition, First Republic, one of SVB's closest competitors, has a cost of deposits exceeding 14 basis points. While SVB does enjoy a cheap source of deposits, we believe there's a substantial opportunity cost attached to its inexpensive commercial deposits. Unlike its competitors and most banks, Silicon Valley Bank's depositors are not retail deposits, but are rather concentrated among startups and the private equity and venture capital funds that invest in them. As a result, SVB Financial is a bank that is highly leveraged to the Silicon Valley funding cycle, and its deposit base can fluctuate wildly. SVB's funding cost may be very low on an absolute basis, but movement in these commercial deposits is difficult to forecast, given startups' tendency to burn cash while routinely needing to raise new capital. These are unlike retail deposits, which tend to be very stable and moaty. From the end of 2008 to 2010, as startups became the hot investment, deposits grew approximately 50% annually. In 2001, after the tech recession, deposits dropped more than 30%. Given this variability in deposits, the bank must keep a substantial portion of its deposits in cash and securities. In 2017, the bank held more than 61% of its on-balance-sheet deposits in cash and securities. In comparison, First Republic keeps only 24% of its deposits in cash and securities. In addition, a flood of new deposits can result in more cash than a bank can effectively deploy, which we believe has happened. From an operational perspective, the bank enjoys an efficiency ratio of 51.1%, which is respectable.

SVB Financial maintains that its long history and strong relationships within the Silicon Valley community provide a competitive edge in lending to private equity and venture capital firms and entrepreneurs. We believe there is some validity to this statement. Silicon Valley Bank lends significantly to private equity and venture capital funds in the form of capital call lines of credit. These are short-term loans that enable these funds to delay calling capital from investors, which increases the internal rate of return these funds report to their investors. For example, if a private equity firm raises capital for a fund lasting five years and uses a capital call line of credit provided by Silicon Valley Bank for the first six months of the investment, it enables it to reduce the time and the cost of capital used to calculate its internal rate of return. Usually, these lines of credit are short-term loans ranging from three to six months and are backed by investor commitments. These loans are repaid as soon as the private equity or venture capital fund calls capital from its investors. These loans have grown rapidly at Silicon Valley Bank. At the end of 2017, private equity and venture capital loans accounted for more than 40% of the total loan book, up from 15% in 2012. The company trumpets the low-risk nature of these loans, given their short-term nature. While these loans have been profitable, they are also highly transactional and depend on deal activity. If deal activity continues to slow, it is almost certain that the bank would see significant negative loan growth, something few investors are anticipating.

Throughout much of the bank's history, SVB Financial has been able to generate returns in excess of its cost of capital by successfully lending to venture-capital-backed companies, often profitless firms that are shunned by many traditional lenders. These are companies that likely have little in the way of assets, are generating losses, possibly have an undefined business model, and whose ability to repay depends on reaching an initial public offering or being acquired. As a result, SVB was able to charge borrowers high rates of interest and attach equity warrants to their loans, giving Silicon Valley Bank significant upside should a borrower be acquired or complete an IPO. In 2017, gains on warrants accounted for almost 6% of the bank's pretax income. SVB maintains that its unique position within the Silicon Valley ecosystem has provided it with better information to identify which companies will generate significant growth and possibly even achieve an IPO or be acquired. Before 2009, Silicon Valley Bank enjoyed little competition and had the ability to pick and choose to whom they lent by identifying the best early-stage companies sooner than its peers. Until recently, this segment of lending was a small niche dominated by a few small banks. However, we believe this has changed as new lenders have entered the venture debt market, putting pressure on the rates and terms Silicon Valley Bank can offer. Today, Silicon Valley Bank is competing against large lenders like Comerica, business development companies, hedge funds, and even nonfinancial startups to provide funding to companies. Simply put, our view is that Silicon Valley Bank is taking equitylike risk, but earning bondlike returns. Going forward, we believe increased competition will be reflected in charge-offs, negative growth in loans and deposits, and a higher efficiency ratio. We believe this increased competition supports our thesis that SVB Financial lacks a moat.

SVB Financial operates in the U.S. banking system, which we assess as fair from a stability perspective. Though regulation has become considerably stronger in the past several years, the country still uses a complex and somewhat archaic system of regulation. Furthermore, the company's banking market is quite fragmented; Silicon Valley Bank must compete with a variety of regional and community banks, as well as large money-center institutions. Over the past 50 years, the banking system has achieved returns in line with its cost of capital, which supports our view of the environment as intensely competitive. Our outlook is more positive from a macroeconomic and political standpoint. The U.S. is still the world's leading democracy, has increased GDP at a steady pace for years, and maintains the world's reserve currency, all of which contribute to banking stability.

Fair Value and Profit Drivers 
| by Colin Plunkett Aug 10, 2018

We are raising our fair value estimate to $98 per share from $93, due to an increase in the time value of money. As of June 30, 2018, our fair value estimate is about 1.1 times book value per share. We still believe that Silicon Valley Bank's commercial loan portfolio is of low quality and are convinced credit performance will eventually deteriorate. We now forecast the bank to more gradually shrink its loan and deposit portfolio, rather than a sudden downturn. That said, when the venture capital market turns, we don't expect the changes in the bank's balance sheet or deposit base to be gradual or modest. We still think in five years, SVB Financial will be a smaller bank in a more competitive market.

Over the past decade, venture capital deal activity has grown at a compounded rate of 9%. More recently, deal activity has grown by more than 20% on average over the past five years. If we assume sustainable growth in venture capital activity was closer to 9% starting in 2014 (with excess growth representing a bubble in activity), and that SVB Financial's portfolio growth mirrors total venture capital deal value, that would imply that the bank's loan portfolio would need to shrink by 25% over the next five years. Over the next five years, we therefore assume loans fall by about 24%; however, this could happen more quickly than we expect. We anticipate deposits would shrink by about 20% as well. It is likely the bank will search for higher-cost deposits elsewhere in the event of a declining core customer deposit base.

We're forecasting that net charge-offs peak in 2020 at about 2.2% of total loans. In previous peaks, net charge-offs reached 3.3% and 2.5% in 2009. Today, the bank is more tilted toward private equity capital call lines, which should perform better in the event of a downturn. That said, we think the rest of SVB's loan portfolio is materially worse than in previous cycles.

We still believe SVB will benefit from rising interest rates, but we doubt that the bank will enjoy this cheap of funding if deposit growth turns negative. The bank will likely have to go out and pay up for deposits. In light of this, we expect net interest margins to increase only 170 basis points to 4.9% in 2022 from 3.2% in 2017.

Risk and Uncertainty 
| by Colin Plunkett Aug 10, 2018

The greatest risk to SVB would be a prolonged slowdown in exit markets and venture capital and private equity funding. This would likely result in significantly increased charge-offs and allowances for loan losses. We do worry that this most recent tech cycle, unlike previous cycles, has been partly fueled by leverage. Charge-offs could very well exceed previous slowdowns in funding. In 2000, charge-offs peaked at 3.33% of average loans. In addition, the bank's deposits can be highly volatile at the beginning and during the emergence of recessions. In the first quarter of 2001, deposits declined more than 30% year over year and rebounded 38% at the end of 2008. While the bank enjoys a low-cost deposit base, 50% of which belong to early-stage companies, we worry how sustainable many of those businesses are, given their unproven business models and tendency to burn cash. Should the bank experience a significant reduction in deposits, it may need to pay up to acquire new types of deposit funding. This would likely result in a significant reduction in net interest margin. We also believe a slowdown in the innovation economy would cause a significant reduction in fee income, as the bank's noninterest income is derived from startup economy.

Stewardship 
| by Colin Plunkett Aug 10, 2018

We view SVB's stewardship of shareholder capital as Poor. Given the flood of investment into Silicon Valley and increased competition to provide companies with venture debt, we would prefer a bank to operate with more skepticism and be willing to walk away from deals. Greg Becker has been CEO of the company since April 2011. Under his leadership, loans have grown from $5.6 billion to $23 billion, a compounded growth rate of more than 23%, leading us to believe that he and his team have walked away from few, if any, deals. In comparison, Becker's predecessor Ken Wilcox, of whom we have a favorable opinion, increased loans at an annual rate of only 12%. Unlike the late 1990s, when companies were coming to market with little to no debt, this tech cycle seems to be more enamored with leverage, and SVB has been an enthusiastic participant. Jet.com, a highly profitable loan made by this management team, raised $565 million in equity capital. In addition to that equity, Jet.com received at least $125 million in debt finance, at least some of which came from Silicon Valley Bank. While the investment worked out well, we believe it entailed a substantial amount of risk given the amount of debt, the questionable business model, and the rate at which we suspect the startup was burning cash. It is unlikely that management could have known in September of 2014 when the loan was made that it would result in an acquisition by Walmart. In comparison, at the end of 1997, Amazon had about $76 million in debt, but it was only after the company went public do we find any debt in its public filings. EBay, another tech darling of that era, didn't have any debt at the time of its IPO. In contrast, today's darling, Uber, has raised over $3 billion in debt, though we are not aware of any involvement by SVB. In addition, another unicorn, WeWork, is reported to have sought a $750 million credit line in November 2015. However, unlike Uber, WeWork has an unproven business model, providing short-term office leases to fledgling companies. We are not aware of SVB providing any loans to WeWork. However, we believe this demonstrates that this tech cycle has partly been fueled by debt. It is our opinion that management has not been shy about providing credit to increasingly shaky credits in the innovation economy and supports our opinion that the company has been a poor steward of capital.

In addition, the bank has boasted about its global reach and ability to secure a Chinese banking license to provide banking services denominated in Chinese yuan in mainland China. At best, we believe that Chinese expansion lies far outside this bank's circle of competence and is a waste of management's time and shareholders' capital. At worst, we believe this is promotional and exemplifies the bank's willingness to take risk without generating a commensurate return.

Mstar of SIVB Jan 2019

Silicon Valley Bank's Net Interest Margins Get Back on Track in 4Q
Colin Plunkett
Equity Analyst
Analyst Note Jan 26, 2019

Silicon Valley Bank resumed its net interest margin expansion in the fourth quarter, as margins expanded 7 basis points to 3.69%. Over the past year, net interest income has grown nearly 31% to $517.4, driven by higher rates and strong loan growth, particularly within capital call lines of credit. For the quarter, the bank earned $4.96 per share, while pretax income jumped 46% from the previous year. Silicon Valley Bank has had basically no significant credit provisions over the past year despite what we view as a low-quality loan portfolio. We believe investors are valuing the bank based on a cyclical peak in profitability and growth. When management says competition for loans remains fierce, we urge investors to believe them. For now, we'll be maintaining our fair value estimate of $98 per share. However, as we digest full-year results and update our 2019 forecast, investors should expect an increase in our fair value comparable to the increase in book value per share.

For the period, Silicon Valley Bank grew loans 3% from the previous quarter and nearly 23% from the end of 2017. A vast majority of Silicon Valley Bank's loan growth is coming from private equity and venture capital. Though healthcare lending has still seen strong loan demand, the bank saw negative growth in its loans to software and hardware companies in the quarter. Loans in Silicon Valley's private equity/venture capital segment now account for nearly 50% of the bank's entire loan portfolio. To put this in perspective, just three years ago these loans accounted for about a third of the entire portfolio.

Mstar of Nike

Wide-Moat Nike's Digital Efforts Give a Boost to all Regions in 1Q; Shares Attractive
David Swartz
Equity Analyst
Analyst Note | by David Swartz Updated Sep 25, 2019

Wide-moat Nike exceeded our sales and margin expectations in fiscal 2020's first quarter, led by growth in greater China and Nike's digital efforts (42% currency-neutral growth). The firm beat our forecast of 5.5% sales growth with 7.2% (10% currency-neutral) growth in the quarter. Nike bettered our growth expectations in all regions, including greater China, where we believe it continues to take share from both native and international brands. Nike's 21.8% (27% currency-neutral) growth in the region beat our forecast of 16.0% growth due, in part, to 70% digital growth. We forecast greater China will grow to 30% of revenue in fiscal 2029 from 16% of revenue in fiscal 2019. Greater China, Nike's most profitable region, produced an operating margin of 39.8% in the quarter and contributed to a strong overall operating margin of 15.1%. This result beat our forecast of 12.7% and represented a year-over-year improvement of 170 basis points. While greater China was a standout, Nike also performed well in North America and Europe, the Middle East, and Africa, where we believe it continues to benefit from the athleisure fashion trend and its traditional dominance in performance apparel. Also, we think its efforts to restrict its product to key wholesale partners and its own direct-to-consumer channels are working. For example, Nike's digital revenue in North America increased by more than 30% in the quarter.

Overall, Nike's EPS of $0.86 in the first quarter handily beat our forecast of $0.70. We expect to increase our fair value estimate of $98 by a low-single-digit percentage. We view the quarterly report as particularly impressive considering the unfavorable strengthening of the United States dollar and a generally difficult apparel market in North America. Although Nike appreciated more than 4% after the quarterly announcement, we view shares as undervalued.

Business Strategy and Outlook | by David Swartz Updated Aug 01, 2019

We view wide-moat Nike as the leader of the athletic apparel market. Our wide moat rating is based on Nike's intangible brand asset, as we believe it will maintain premium pricing and generate economic profits for at least 20 years. Nike, the largest athletic footwear brand in all major categories and in all major markets, dominates categories like running ($5 billion in annual sales) and basketball ($4 billion in annual sales) with well-known brands like Jordan, Air, and Pegasus. Nike faces significant competition, but we believe it has proved over a long period that it can maintain share and pricing.

We think Nike's strategies allow it to maintain its leadership position. In mid-2017, Nike announced a consumer-focused realignment. Nike is investing in its direct-to-consumer network while reducing the number of retail partners that carry its product. The firm is reducing its exposure to mediocre, undifferentiated retailers while increasing distribution through a small number of retailers, like narrow-moat Nordstrom, no-moat Dick's Sporting Goods, and Foot Locker, that bring the Nike brand closer to consumers. At Nordstrom, for example, Nike operates its own shops with its own salespeople, allowing it to control the brand message. Nike's consumer plan is led by its Triple Double strategy to double innovation, speed, and direct connections to consumers. Triple Double includes cutting product creation times in half, increasing membership in Nike's mobile apps, and improving the selection of key franchises while reducing its styles by 25%. We think these strategies will allow Nike to hold share and pricing.

We believe Nike has a great opportunity for growth in China and other emerging markets. Nike has experienced double-digit growth in each of the last four fiscal years in China, and we expect it will continue to do so for at least the next 10 years. Nike should benefit from heavy investment in sports by the Chinese government. Moreover, Nike, with worldwide distribution and $3.8 billion in fiscal 2019 digital sales, will benefit as more people in China, India, Latin America, and other emerging countries move into the middle class and gain broadband access.

Economic Moat | by David Swartz Updated Aug 01, 2019

We maintain a wide moat rating on Nike based on its intangible brand asset. Nike is the largest athletic apparel company in the world. Its revenue more than doubled in the past 11 years to $39.1 billion in fiscal 2019 from $18.6 billion in fiscal 2008 and has increased in 10 of the past 11 years. Nike produces apparel and footwear for professional and amateur athletes, sports equipment, and sports-inspired fashion for both athletes and nonathletes alike. As evidence of its competitive edge, Nike's adjusted ROICs, including goodwill, have averaged 33% over the past 10 years. We forecast that the company's average annual adjusted ROICs, including goodwill, will exceed its weighted average cost of capital over the next 20 years, as required for our wide moat rating. We estimate Nike's weighted average cost of capital at 9% and expect its adjusted ROICs, including goodwill, to average 44% over the next decade. We believe Nike has been the preferred sportswear brand in the world since the 1980s and that it will remain so for many years.

Nike achieves premium pricing on many products, supporting our view of its brand power. Its performance athletic shoes are the most expensive on the market. At no-moat Dick's Sporting Goods, for example, Nike produces 70% (30 of 43) of the styles of men's soccer cleats that cost more than $200 per pair. At footlocker.com, Nike produces 92% (24 of 26) of the styles of the men's performance basketball shoes that cost $175 or more per pair. At finishline.com, Nike produces 94% (32 of 34) of the styles of men's running shoes that cost $190 or more per pair. Some fashionable Nike shoes retail for prices associated with luxury footwear brands. Luxury retailer farfetch.com lists 21 styles of Nike sneakers at prices above $1,000 per pair and dozens more that retail for at least $300 per pair. Moreover, as evidence of Nike's enduring popularity, older and limited-edition Nike shoes are regularly sold in resale markets for thousands of dollars per pair.

We believe Nike's wide moat is supported by its worldwide reach. The company ships products to more than 30,000 retailers in more than 190 countries. In 2018, Nike shipped about 1.3 billion units and had about 110,000 points of distribution. Nike operates 1,200 stores (two thirds outside of the U.S.) itself and another 6,000 or so Nike-branded stores are operated by franchisees throughout the world. Nike's $39.1 billion in fiscal 2019 revenue was about 60% greater than that of its closest competitor, narrow-moat Adidas. Nike produced $24.2 billion in fiscal 2019 footwear sales, more than the combined footwear sales of Adidas, Puma, and no-moat Under Armour. Nike has market-leading share in footwear in all markets and major categories and ships about 800 million pairs of shoes per year. Nike is also the leader in athletic apparel, producing $11.6 billion in apparel sales in fiscal 2019. Although Nike is an American brand, 59% of its fiscal 2019 revenue was produced outside of North America. We believe that no athletic apparel company will be able to approach Nike's global market share in at least the next 20 years, supporting our view that it has a wide moat.

Nike's brand is enhanced by its large e-commerce business in the U.S. and other countries. We estimate that Nike generated about $3.8 billion in e-commerce sales from its digital marketplaces in fiscal 2019, up from about $1.5 billion in fiscal 2015. Nike expects digital sales to increase to as much as 30% of its sales by 2023. We think this growth is achievable as more consumers in developing markets (such as China, India, and Latin America) move into the middle class and gain access to broadband services. Nike is investing heavily in its digital services. Its apps, known as NikePlus, have more than 100 million members. Its Training Club and Run Club apps are the largest apps in their fields in the U.S. and Europe. Its SNKRS app for hard-core shoe collectors reportedly has several million members. Nike produces limited-edition products that are exclusive to members of NikePlus. For example, more than one third of Cristiano Ronaldo's Mercurial soccer cleats are available only on nike.com and its apps. Many Nike-sponsored athletes, including Ronaldo and Brazilian soccer star Neymar, have tens and even hundreds of millions of social media followers. Nike uses their fame to promote its products to a huge audience at relatively low cost. The firm supports its e-commerce with some innovative digital products, such as NikeConnect, a service that allows people to take a picture of a Nike product and identify it. This is a useful service, as Nike estimates there are 5 billion individual Nike products in the world. We believe Nike's large digital community creates goodwill among its best customers and promotes the brand. While other athletic apparel companies have e-commerce, none of them have the reach of Nike. We think Nike's apps support our wide moat rating.

Nike sponsors many of the world's most popular athletes and teams in virtually all major sports. It has endorsement deals with 54 of the 100 athletes on Forbes' 2018 list of the world's highest-paid athletes. Athletes sponsored by Nike include Cristiano Ronaldo (soccer), Neymar (soccer), LeBron James (basketball), Kevin Durant (basketball), Kyrie Irving (basketball), Mike Trout (baseball), Giancarlo Stanton (baseball), Rafael Nadal (tennis), Serena Williams (tennis), Simone Biles (gymnastics), Matt Ryan (football), Alex Morgan (soccer), many track and field athletes, and retired basketball players Michael Jordan and Kobe Bryant. Teams and leagues sponsored by Nike include the NFL, the NBA, many U.S. and international college teams, many national soccer leagues, and the national soccer teams of numerous nations, including Brazil, France, and England. Nike is the sponsor of choice for athletes and teams due to its status as the world's largest apparel brand and the tremendous success of its 35-year relationship with Michael Jordan. LeBron James famously turned down more money from Reebok to sign with Nike in 2003, ultimately dooming Reebok to irrelevance in basketball shoes. In 2019, Nike's Jordan Brand bested all rivals to sign NBA rookie Zion Williamson. Whether sponsored or not, professional and amateur athletes all over the world wear Nike apparel while competing. For example, its Mercurial line of soccer cleats is the most popular brand in England's Premier League. Also, 73% of the players in the NBA wear Nike or Jordan shoes. We expect Nike's powerful brand will continue to allow it to sign the key endorsement deals that will keep it on top.

Nike's brands have proven staying power, supporting our view that it can continue to earn economic profits for at least the next 20 years. Michael Jordan signed with Nike in 1984 and retired from basketball in 2003. Many millennials are not even old enough to have seen him play. Yet, the Jordan brand produced more than $3 billion in (wholesale-equivalent) sales in fiscal 2019. If it was an independent company, the Jordan brand would be the third-biggest athletic footwear brand in the U.S. behind only other Nike footwear and Adidas. While Jordan is Nike's biggest star, Kobe Bryant and LeBron James have also proved they can sell shoes over a long period. Bryant's signature shoes remain big sellers and are worn by more NBA players than any other, even though Bryant retired in 2016. James' shoes, meanwhile, have been big sellers for Nike since he was a teenager. He signed a new contract with Nike in 2015 that will reportedly pay him $30 million per year until 2048 (when he celebrates his 64th birthday). Nike, which ships about twice as many pairs of shoes worldwide as Adidas, has developed franchises with unusual longevity. We think Nike's key brands support our view that it has a wide moat based on its brand intangible asset.

We believe Nike's innovations contribute to its brand and support our wide-moat view. Nike has been known for its innovative products ever since it introduced running shoes with pressurized air in their soles in the 1980s. Nike frequently releases new styles of running shoes. Recent editions to its large family of shoes include Epic React (foam cushioning), VaporMax (new style of Air), and shoes with ZoomX technology. ZoomX is Nike's answer to Adidas' popular Boost line of running shoes. Nike claims the ZoomX substance was developed for the aerospace industry and returns as much as 85% of energy to the runner. While it may be hard to prove this claim, Nike's dominance in running shoes is clear as the category produces more than $4 billion in sales for the company. Most of the world's leading track and field athletes wear Nike shoes. Nike's innovation allows it to maintain premium pricing. Many Nike running shoes, such as the best-selling Air Zoom Pegasus, sell at prices over $100 per pair. Nike Air Vapor Max, which sell for about $190 per pair at Foot Locker, reportedly became the best-selling running shoe above $150 per pair within months of its launch in 2017. We believe Nike is the leader in sports performance technology, providing a persistent competitive edge.

We do not believe Nike has a moat based on a cost advantage. Nike may have some cost advantage over competitors in sponsorships due to its status as the premier sportswear brand. But we don't view this as significant or sustainable. The cost of sponsorships has been rising as new companies (including Puma, New Balance, narrow-moat Anta, and Under Armour) have become active in the market. Moreover, while endorsements are great for brand building, they are difficult to quantify in terms of profit margins. While Nike's operating margins of 12% to 13% are very good, it is difficult to know if endorsements play a major role. It is possible that Nike simply has expense leverage due its size. Nike has limited advantage in product costs as virtually all its production is outsourced to more than 400 independent factories in about 40 countries. Narrow-moat Shenzhou International, for example, is one of Nike's largest suppliers but also produces apparel for Adidas, Puma, and others. We do not believe, therefore, that Nike has a moat based on any cost advantage.

We do not believe Nike has a moat based on anything aside from its brand intangible asset. We do not think it has a moat base on efficient scale. While Nike's financial resources and relationships with suppliers likely allow for production investment unavailable to others in the short term, any advantage in this area is unlikely to be sustainable. Competitors can probably gain access to similar technologies. Moreover, much of apparel manufacturing remains manually intensive. We do not believe there is any network effect in the apparel business and switching costs are nonexistent. Competing products to Nike's footwear and clothing are widely available.

Fair Value and Profit Drivers | by David Swartz Updated Aug 01, 2019

We maintain our fair value estimate on Nike of $98. Our fair value estimate implies a fiscal 2020 adjusted P/E of 34 and a 2019 EV/adjusted EBITDA of 24. Nike's fiscal 2019 fourth-quarter sales of $10.18 billion slightly exceeded our $10.16 billion forecast. In greater China, sales growth of 15.6% (22% currency-neutral) beat our estimate of 13.0%. Nike's fourth quarter EPS of $0.62 came in just below our $0.63 forecast due to a difference in share count and a higher tax rate. However, Nike's tax rate has declined over the past few years as the company has avoided taxes by using offshore accounts in low-tax jurisdictions. We expect Nike will achieve sales growth in the high-single digits (excluding currency) in fiscal 2020. We think currency headwinds may reduce Nike's fiscal 2020 first-quarter gross margin by 50-70 basis points. We forecast 40- and 60-basis-point improvements in Nike's gross and operating margins in fiscal 2020.

We expect average annual sales growth rates for Nike of 7% over the next 10 years. We expect Nike will achieve annual growth rates of 3% to 5% in the North America market, in line with expected market growth. We think Nike's innovative product and e-commerce will allow it to hold its market position and premium pricing. In Greater China, Nike's fastest-growing segment, we expect annual growth rates of 13% or higher for at least the next 10 years. Nike, the market leader in China, is poised to benefit from high investment in sports by the Chinese government and the growth of the Chinese middle class.

We think Nike's operating margins will rise as it increases sales in profitable markets. We forecast operating margins will gradually increase to 17% from 12% in fiscal 2019 over the next decade. In greater China, Nike has achieved segment operating margins above 35% in each of the last four years and we think it will continue to do so. Nike is viewed as a premium brand in China and its product achieves premium pricing. We expect will continue to take share from weaker native brands. In North America, we forecast segment operating margins of about 25%, in line with the segment operating margin achieved in fiscal 2019. We think Nike can overcome discounting at mass retailers through e-commerce and specialty retail.

We forecast Nike's gross margins will improve to 48% in fiscal 2028 from 45% in fiscal 2019. Nike may increase gross margins through greater production and distribution efficiencies and price increases.

Risk and Uncertainty | by David Swartz Updated Aug 01, 2019

We assign a medium uncertainty rating to Nike. The firm is exposed to weakness in U.S. physical retail. Department stores that carry Nike products, including no-moat Macy's and J.C. Penney, have closed stores and are likely to close more. In 2018, department store chain Bon-Ton, which carried Nike products, went bankrupt and closed its stores. The sporting goods channel has also been challenged. The 2016 shutdown of Sports Authority affected Nike and other athletic apparel companies in the U.S. In response, Nike took the possibly unprecedented step of reducing its minimum advertised price to move excess inventory. Nike may be able to make up for weakness in some areas of retail through direct-to-consumer sales and sales through retailers that are not closing stores, such as narrow-moat Nordstrom.

The athleisure trend and growth in activewear has attracted new competition. While Nike is the market leader in many categories and many markets, some competitors have found success with fashionable specialty products. Narrow-moat competitors Adidas, VF's Vans, and Lululemon have grown faster than Nike in North America over the past few years. Some of these competitors are expanding outside of North America to markets like China, where they will directly compete with Nike. Nike also faces competition in China from native brands like narrow-moat Anta Sports Products. While competition is nothing new for Nike, changing fashion trends could affect some of its product lines.

Nike's production is outsourced to roughly 400 factories in more than three dozen countries. As factories in China produce about 26% of Nike's footwear and apparel, any trade dispute between China and the U.S. that increases tariffs or other barriers to trade could entail higher costs. But we think any trade disputes will be short-lived. Moreover, Nike can likely shift some production to countries like Vietnam and Indonesia if necessary.

Stewardship | by David Swartz Updated Aug 01, 2019

We assign a Standard stewardship rating to Nike. Over the past 15 years (as of July), Nike has a generated an average annual return to investors of 17%, well above the 10% average annual return of the Morningstar U.S. Market Total Return Index. Nike is the largest U.S.- based apparel firm and the largest athletic apparel company in the world. Nike's revenue has more than doubled over the past 11 years, having increased to $39.1 billion in fiscal year 2019 from $18.6 billion in 2008. Nike's adjusted ROICs, including goodwill, have averaged 35% over the past five years, well above its estimated weighted average cost of capital of 9%.

Nike has had stable management. In 2004, Phil Knight, who co-founded the company in 1964, resigned as CEO but remained chairman. In 2006, Mark Parker was named CEO. Parker has been employed by Nike since 1979 and has served in a few different managerial roles at the company. In 2015, Nike announced an ownership and management transition plan. The company announced Knight would retire as chairman and be replaced in the position by Parker. Further, Phil Knight's son Travis, a professional animator, joined Nike's board. At the same time, Nike announced that Phil Knight had transferred most of his Class A shares to a new company called Swoosh. The Class A shares are not publicly traded but can be exchanged one for one into the publicly traded Class B shares. Under Nike's structure, the Class A shareholders appoint 75% of Nike's board while the Class B shareholders appoint the rest. Swoosh is governed by a board of directors with four members, including Parker and Travis Knight (who has two out of five total votes). Thus, a few insiders can appoint most of Nike's board. Phil Knight continues to attend Nike board meetings as its nonvoting chairman emeritus. We view Nike's governance structure as suboptimal, as outside shareholders have limited say in the composition of its board. Also, we prefer the CEO and chairman roles to be split to improve oversight of management. However, we believe that Nike's governance structure has worked well for shareholders and provides stability.

Nike's board consists of 12 members, 10 of whom are considered independent. Parker is the only board member who also serves as an executive. There is a lot of management and business experience on Nike's board. We think it could use more representation from the apparel industry, though.

We think Nike's compensation policies could be improved. Executives receive most (80% or more in fiscal 2019) of their annual compensation based on performance targets rather than salary. We view compensation plans of this type as favorable as they encourage executives to create value for shareholders. However, Nike's performance-based annual cash bonuses are based solely on earnings before interest and taxes, and its long-term bonuses are based on EPS and revenue targets. We prefer performance targets based on ROICs and cash flows, as these create value for shareholders.

We think Nike has created value through acquisitions and dispositions. In 2003, Nike bought Converse for $305 million. Converse, known for its casual athletic canvas shoes, had gone bankrupt in 2001 and had just $205 million in sales in 2002. The Converse deal has been successful. In fiscal 2019, the brand produced $1.9 billion in sales and more than $300 million in operating profit. While Nike continues to own Converse, it has divested other brands. In 2012, for example, it sold Cole Haan for $570 million, 24 years after it had bought it for $95 million. We view dispositions of niche brands as beneficial to shareholders as they allow Nike to focus on its core business.

Nike has returned significant cash to shareholders through dividends and stock buybacks. The company will issue about $1.5 billion in dividends in fiscal 2019. Nike's dividend payout ratio has been around 30%, and we expect it will maintain a dividend payout ratio around this level. Nike also returns cash to shareholders through buybacks. In November 2015, the company authorized a four-year, $12 billion stock repurchase program. In June 2018, its board authorized a new four-year, $15 billion stock repurchase program. Nike completed the 2015 buyback in the third quarter of fiscal 2019, having repurchased 192.1 million shares at an average price of $62.47. Nike is now repurchasing stock under the 2018 program. Nike has reduced its share count by approximately 18% over the past decade, and we expect it will repurchase more than $17 billion in stock in over the next five years. But we believe that Nike reduces shareholder value if it repurchases shares at prices above our fair value estimate. In 2014-15, Nike repurchased billions of dollars of shares at prices above our fair value estimate. If the company had halted buybacks instead, it could have conserved cash for greater share buybacks in 2016-17 at prices below our fair value estimate.


2019年9月20日 星期五

Mstar of CCI 2017

Crown Castle's small-cell expertise differentiates it from other tower firms.
Alex Zhao
Equity Analyst
Business Strategy and Outlook 
| by Alex Zhao Mar 11, 2016

The wireless-tower industry provides access to fantastic cash flow. Long-term contracts and, more critically, high switching costs, provide a solid base of future business. We don't believe wireless carriers can escape the need to build denser cell site grids to add data capacity, and Crown Castle has, in our view, built the premier set of assets to help the carriers meet this need. Crown has focused all of its energy on the U.S. market, making acquisitions to broaden its small-cell and backhaul capabilities, two critical elements necessary to augment the coverage traditional wireless networks provide. While Crown lacks the international growth potential of its two tower peers and is more heavily exposed to consolidation in the U.S. wireless market, we believe it will prove an especially indispensable partner for U.S. carriers.

Crown earns the vast majority of its revenue by leasing out space on communications towers it owns or otherwise controls. Contracts with wireless carriers typically run 10 years or longer and include annual rent escalators. The majority of these wireless towers were acquired in chunks, primarily from the carriers themselves. Tower firms can manage towers more efficiently than the carriers, as independent ownership allows multiple carriers to locate on each structure without competitive concern. The tower companies also possess deep tower-management expertise that can be effectively leveraged across far more sites than a carrier could accomplish on its own.

Crown's nearly exclusive focus on the U.S. market has led it to types of assets its rivals have largely or entirely ignored. The acquisition of NextG in 2012 pushed the firm heavily into the DAS and small-cell markets, and the purchase of Sunesys brought deep fiber assets in several markets. While the returns on these assets probably won't match the traditional tower business, we believe Crown is assembling a collection of assets that will collectively allow the firm to offer unique solutions to the carriers as they fill network gaps and add coverage in high-traffic areas.

Economic Moat 
| by Alex Zhao Mar 11, 2016

Crown Castle's narrow moat is based on the attractive locations of its towers, which we reflect as an efficient scale advantage, and the high switching costs its customers would face in moving equipment en masse from one tower vendor to others. These advantages are typically codified in long-term contracts with customers (typically 10 years or longer) that call for 2%-4% annual rent escalators. At the end of 2015, about 72% of our site leasing revenue forecast for 2016-20 was already under contract. The tower business model enables the wireless telecom industry to operate more efficiently as multiple carriers collocate on the same physical structure rather than build single-use tower sites. Carriers looking to expand or improve coverage are likely to first look for adequate existing structures in a particular area before investing the time and money needed to permit, build, and equip a new tower. Adding a tenant to an existing tower produces very high-margin incremental revenue with no or modest up-front capital needed.

Equipment is rarely removed from a tower once it has been placed into service. Moving equipment to another tower is an expensive endeavor and risks service disruption or changes in coverage that could anger customers. Thus, decisions to remove equipment are heavily deliberated and typically only made in conjunction with major network overhauls. Churn typically totals 1%-2% of rental revenue, with carrier acquisitions accounting for a large portion of lost business. Crown Castle's churn has spiked beyond this range recently (to 3%-4%) as a result of its relatively large exposure to recent U.S. carrier acquisitions (Leap, MetroPCS, and Clearwire). Offsetting churn, carriers frequently seek to add additional equipment to existing sites to upgrade technologies or add antennas to utilize additional spectrum bands. With the expansion of LTE networks in recent years, this amendment activity has driven strong revenue growth.

Land ownership represents a key risk to Crown Castle's competitive position. Historically, towers have been built on third-party sites, with ground rent representing the largest operating expense for the tower owner. Crown has spent more than $1 billion over the past decade in an attempt to better control the land beneath its towers. Today, the firm owns or otherwise controls the land under about 22% of its U.S. towers, representing about 27% of site rental revenue and 36% of rental gross profit. Where land can't be purchased, Crown has worked to extend ground leases far into the future. In the U.S., the average lease term now extends about 30 years. Ground leases under only about 14% of Crown's tower sites expire during the next decade.

Heavy customer concentration and the risk of technological change limit our moat rating. Crown Castle's domestic focus leaves it the most heavily exposed of the three public U.S. tower companies to U.S. wireless carriers. The four nationwide U.S. carriers now account for more than 90% of leasing revenue, with AT&T and T-Mobile accounting for 30% and 22%, respectively. We estimate that payments to the three publicly traded tower companies now represent about a fifth of Verizon's total recurring cost of serving wireless customers, making tower rent a major expense to manage.

In addition, new network architectures like small cells and distributed antenna systems may reduce demand for traditional tower sites in the future. Crown Castle made an aggressive move into the DAS market with the 2012 acquisition of NextG Networks and subsequent heavy investment in new DAS sites. The economics of the DAS business are likely less favorable than the traditional macro site market. This business also represents only about 10% of Crown's leasing revenue, though it is growing rapidly. In addition, with the move to deploy small cells, individual traditional sites may decline in importance. This dynamic could enable the carriers to more easily play tower vendors off each other, threatening to withhold new business or selectively move equipment to other towers to negotiate better rates over time.

Fair Value and Profit Drivers 
| by Alex Zhao Jul 20, 2017

Our fair value estimate for Crown Castle is $95 per share, after accounting for the acquisition of Lightower, which is likely to close by the end of 2017. We expect reported site rental revenue growth (non-cash and excluding Lightower) to accelerate to between 7% and 10% in 2017 through 2021, as the carriers begin to ramp up network construction. In addition, we expect Lightower to contribute $860 million in revenue in 2018. Crown hasn't been aggressively building new traditional towers recently, focusing instead on small cells, a trend we expect to continue. Therefore, we anticipate more growth comes from the small-cell business over the next few years as traditional site leasing matures.

We expect Crown's adjusted EBITDA margins to steadily expand over the next five years as the firm leverages its land position. Ground lease expense represents, by far, the largest cost of doing business. Adding tenants or increasing the space leased to an existing tenant generally has no impact on land costs, allowing most of this incremental revenue to fall to the bottom line. We also expect capital spending will decline over the next few years as Crown wraps up its land purchase program and the construction of new small-cell sites slows.

Risk and Uncertainty 
| by Alex Zhao Mar 11, 2016

Crown Castle faces the same risks as its tower rivals, with major carrier consolidation the biggest potential threat. Recent mergers in the U.S. have involved relatively small carriers like MetroPCS and Leap, limiting the impact on the demand for tower space overall. A more significant deal, like a Sprint merger with T-Mobile, would likely have far deeper implications for tower demand while also concentrating negotiating power in the hands of fewer customers. Crown Castle's lack of geographic diversity leaves it particularly heavily exposed to U.S. consolidation.

Changes in consumer demand for wireless services and next-generation technology deployments could also affect demand for wireless data services and, thus, space on wireless towers. For example, small cells, including WiFi networks, could significantly alter the wireless network landscape. Crown Castle has taken several steps to build out assets that will benefit the company as more small cells are deployed, but the firm's ability to efficiently monetize these assets is less certain. Small-cell and DAS deployments require extensive work with landlords, and often they can't accommodate as many tenants as a traditional wireless tower.

Land is, by far, the most critical input into the tower business model. Crown owns the land under less than one fourth of its tower sites. Unfavorable negotiations with landlords could sharply cut into margins or force the firm to remove a tower. Fortunately, ground leases typically run for 20 years or more--Crown's average remaining lease term is 30 years.

Rising interest rates could also present a problem for Crown. While its debt maturity schedule is well spaced over the next decade, refinancing at higher rates would likely pressure cash flow growth. Higher interest rates could also cause investors to demand a higher yield for holding Crown shares, pushing its stock price lower.

Stewardship 
| by Alex Zhao Dec 21, 2016

CEO Jay Brown has been with Crown since 1999, rising to treasurer in 2004 and CFO in 2008, before replacing W. Benjamin Moreland in June 2016. A corporate banking veteran, Moreland joined Crown in 1999 and was named CEO in 2008 after spending eight years as CFO. He is currently executive vice chairman of the board.

Crown's 11-member board includes what appears to be a closely knit core made up of Moreland and three other individuals who have served on the board for over 20 years (including another former CEO). Three additional members were appointed in 2002 or earlier, including two former FCC staffers. Previous CEO John Kelly stopped serving on the board in 2016.

Bonuses are primarily based on EBITDA and adjusted funds from operations, two measures that can be managed to the detriment of long-term performance. Executive compensation, however, is weighted far more heavily toward equity than cash.

Crown has taken the most conservative approach to capital allocation of the three publicly traded tower companies. The firm sharply increased its dividend in late 2014 and plans to hold its payout to around 75% of adjusted FFO going forward. This policy will likely limit future acquisition activity as Crown seeks to reduce leverage and invest in its small cell/DAS business. With the U.S. tower market largely rolled up at this point and Crown choosing to focus exclusively on this market, a high dividend payout makes sense.

Mstar of Johnson

Oklahoma Opioid Case Goes Against J&J, but We Expect Appeals Process to Lead to Lower Payment
Damien Conover
Sector Director
Analyst Note | by Damien Conover Updated Aug 27, 2019

In one of the first state opioid cases, an Oklahoma judge ruled against Johnson & Johnson, awarding the state $572 million, well below the over $17 billion the state was seeking in damages. The amount is lower than many had expected, and J&J still plans to appeal the case. We expect the appeals process to take several years, and on appeal, we believe the amount will fall lower as we believe J&J largely provided appropriate marketing support around its opioid drug sales. Overall, we don't expect any change to our fair value estimate or moat rating for the company based on the ruling, and we continue to model in $1 billion in total opioid litigation costs for J&J.

The next steps in the opioid litigation process include other state cases and a likely long appeals process. Following the Oklahoma ruling, we expect an Ohio case will represent the next important step in determining the magnitude of the overall opioid litigation. The lack of early settlements by opioid drugmakers in Ohio (like Purdue's settlement in Oklahoma) suggest this state could be less sympathetic to the plaintiffs. Also, regardless of the outcome in Ohio, we expect the ruling will be similarly appealed, setting up a process that will likely take several years to complete.

The strong balance sheet at J&J likely entices many plaintiffs to target the firm. Within the opioid litigation landscape, plaintiffs are targeting several industries and firms for potentially causing addiction and overdoses of these powerful drugs. However, J&J holds one of the strongest balance sheets and most robust streams of cash flows, which makes it a larger target than many of the smaller specialty drug firms that carry much weaker financial positions. Even though J&J's opioid sales represent a small fraction of the overall prescriptions of opioid sales (less than 1% of state paid opioid prescriptions), we believe the deep pockets of J&J have made the firm a larger target than its opioid sales would suggest.

Business Strategy and Outlook | by Damien Conover Updated Apr 04, 2019

Johnson & Johnson stands alone as a leader across the major healthcare industries. The company maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat.

J&J holds a leadership role in diverse healthcare segments, including medical devices, over-the-counter products, and several pharmaceutical markets. Contributing close to 50% of total revenue, the pharmaceutical division boasts several industry-leading drugs, including immunology drug Remicade and psoriasis drug Stelara. The medical device group brings in almost one third of sales, with the company holding controlling positions in many areas, including orthopedics and Ethicon Endo-Surgery's surgical devices. The consumer division largely rounds out the remaining business lines, and despite manufacturing issues over the past several years, the group still holds many brands with strong pricing power.

Research and development efforts are resulting in next-generation products. The pharmaceutical group has recently launched several new blockbusters. However, relative to the company's size, J&J needs to increase the number of meaningful drugs in late-stage development to support long-term growth. The company has also created new medical devices, including innovative contact lenses and minimally invasive surgical tools.

These multiple businesses generate substantial cash flow. J&J's healthy free cash flow (operating cash flow less capital expenditures) is over 20% of sales. Strong cash generation has enabled the firm to increase its dividend for over the past half century, and we expect this to continue. It also allows J&J to take advantage of acquisition opportunities that will augment growth.

Diverse operating segments coupled with expected new products insulate the company more from patent losses relative to other Big Pharma firms. Further, in contrast to most of its peers, J&J faces the majority of its near-term patent losses on hard-to-make complex drugs, which should likely slow generic competition.

Economic Moat | by Damien Conover Updated Apr 04, 2019

We believe Johnson & Johnson carries one of the widest moats in the healthcare sector, supported by intellectual property in the drug group, switching costs in the device segment, and strong brand power from the consumer group. The company's diverse revenue base, strong pipeline, and robust cash flow generation create a very wide economic moat. An extensive salesforce makes J&J a powerful candidate for a smaller biotechnology company looking to partner on a new drug, which strengthens Johnson & Johnson's ability to bring new products to market.

Johnson & Johnson's diverse operations are a major pillar supporting the wide moat. The company holds a leadership role in a number of segments, including medical devices, OTC medicines, and several drug markets. Further, the company is not overly dependent on one particular operating segment; the pharmaceutical business, medical device group, and consumer products represent 50%, 33%, and 17% of total sales, respectively. Additionally, within each segment no one product dominates sales, as Pfizer's Lipitor did. Despite carrying some lower-margin divisions, J&J maintains strong pricing power and has posted gross margins above 69% during the past five years, validating its strong competitive position.

Johnson & Johnson's R&D efforts support its robust revenue base. In pharmaceuticals, the company recently launched several new blockbusters, which should allow Johnson & Johnson to escape largely unscathed from upcoming patent expirations. Its efforts in medical devices, including minimally invasive surgical tools, should help maintain leadership in several medical device areas as well as support strong pricing power. Further, switching costs remain high with several of the device products. (For example, physicians switching vendors for hip and knee devices could take weeks if not months to learn the new products, which keeps physicians tied to the company's products.) On the consumer side, new product advancements combined with a solid brand power (reinforced by marketing campaigns) should sustain solid pricing power.

Fair Value and Profit Drivers | by Damien Conover Updated May 17, 2019

We are increasing our fair value estimate to $134 from $130 per share based on increased projections for recently highlighted late-stage pipeline drugs, especially new cancer drugs that hold strong pricing power and typically can reach the market with shorter development times. Overall, within the core drivers of cash flow, new immunology and oncology drugs are driving growth. Including the Actelion acquisition, we expect annual earnings per share growth will average 5% during the next five years, as strong growth in new pipeline drugs should offset some patent losses in the pharmaceutical division. We expect relatively flat operating margins over the next several years as waning cost-remediation efforts in the consumer group and increasing cost-containment efforts throughout the firm help offset margin pressure due to the loss of patent protection on several high-margin drugs, including immunology drug Remicade. Also, following 2019, we expect J&J to reduce its dependence on asset sales that the firm uses occasionally to boost overall earnings.

Risk and Uncertainty | by Damien Conover Updated Apr 04, 2019

Johnson & Johnson needs to overcome several roadblocks, including remaining litigation surrounding central nervous system drug Risperdal, talcum powder, surgical mesh products, and metal-on-metal hip and knee implants and several product recalls that could damage its sterling reputation. Over the longer term, the company faces typical healthcare risks such as reduced pricing power from both governments and pharmacy benefit managers, regulatory delays, and nonapprovals as well as increasingly aggressive generic competition for both small-molecule drugs and biologics. In particular, the biosimilar risk to Remicade is increasing, with several biosimilars working to gain more market share.

Stewardship | by Damien Conover Updated Apr 04, 2019

Overall, we view the stewardship at Johnson & Johnson as relatively Standard. While the firm has a good record of making sound capital deployment decisions and consistently generating returns on invested capital above the cost of capital, major recalls, the recent potential overpayment for Actelion and poor turnaround time in addressing manufacturing problems at certain key divisions lead us to a more balanced view of the company's leadership.

Industry veteran Alex Gorsky replaced longtime CEO Bill Weldon, who stepped down from the top position in 2012 after leading Johnson & Johnson since 2002. Given Weldon's age and the rigorous process to find his successor, we didn't see the change in leadership as a red flag. Gorsky brings a strong record of industry experience dating back to 1988, when he began in the industry as a pharmaceutical sales representative for Johnson & Johnson. His subsequent advancement through many management positions in the drug and device divisions at Johnson & Johnson along with a managerial post at Novartis gives him the broad experience needed to run the massive health conglomerate. The first major test of Gorsky's leadership was the $21 billion acquisition of orthopedic device firm Synthes, which was largely driven by Gorsky as head of Johnson & Johnson's device unit. While we believe that acquisition added important exposure to emerging markets and trauma devices, it appears to have had only a small impact on valuation, as the price paid for Synthes largely accounts for incremental benefits gained from the acquisition. The second major test for Gorsky is the recently completed Actelion deal, which we are skeptical will be able to create much value for shareholders due to the high acquisition price relative to our fair value.